Millions of Americans will soon find out How much health insurance premiums will rise next year and cut into their paychecks.
Their increase is likely to be large, Sam Sutton of POLITICO Reportedly, the economic hit to workers will vary depending on how much the employer pays.
What to expect: History shows that workers should prepare for bad news.
After the last recession, employers made workers pay more premiums than they did before 2008. according to the data From the Kaiser Family Foundation Employer Health Benefits Survey. From 2008 to 2010, the average worker’s contribution increased by 25% and their annual bill, adjusted for inflation, increased by $244.
This year, employers may again ask employees to pay given the softening economy and recent health trend surveys. Willis Towers Watson, an insurance advisory firm, three-quarters of health insurers We believe bad customer habits and overuse of the healthcare system are driving up costs.
Local government employees enrolled in New Jersey’s state health benefit program faced a nearly 20% increase in health insurance premiums, but their protests left the state bearing most of the increased costs. I decided to POLITICO’s Daniel Han and Carly Citrine report. Federal officials expect premiums to rise by 8.7%, and unions are unhappy about this, Sutton reports.
In the long run: As the economy grew in the years before the pandemic, so did employers’ burden on insurance premiums.
In 2015 and 2018, workers’ contributions fell further on average.
Matthew Ray, associate director of Kaiser, which specializes in the healthcare market, believes this is because companies have had to compete for workers in a tight labor market.
“Employers want to offer benefits that help them recruit or retain the best workforce possible,” Rae said. “One of the things he’s annoyed employees about is increasing the amount he demands to pay for health insurance and reducing compensation.”
Towards 2024: Kaiser’s Employer Health Benefits Survey shows that, historically, years in which workers’ contributions increased significantly were followed by years in which they increased slightly. If workers are hit hard next year, the tide could turn in the following year.
Here we explore the ideas and innovators shaping healthcare.
People have been lining up to get their own colonoscopies since actor Ryan Reynolds live-streamed a colonoscopy last month.
I don’t know if it has anything to do with his livestream, but three weeks later, I had a colonoscopy appointment. 36% increase Daily value compared to the previous 100-day average. Doctors removed the polyp during Reynolds’ surgery.
Share news, tips and feedback with Ben Leonard. [email protected]Ruth Leader [email protected]Carmen Pawn [email protected] or Grace Scullion [email protected]
Send tips securely SecureDrop, Signal, Telegram, or WhatsApp.
today our pulse check In a podcast, Lauren Gardner gives Daniel Payne a case study of the risks in the FDA’s accelerated approval program on why the FDA has been trying for years to revoke approval of the pregnancy drug Makena. increase.
Access to healthcare is a matter of life and death.
That’s why regulators are under pressure to approve promising drugs more quickly.
But the case of Makena, an injectable drug touted to lower the risk of premature birth, shows that there are risks in quick action.
FDA advisers said following promising early tests that garnered FDA approval under the FDA’s accelerated approval program in 2011, drug company Covis Pharma has never proven its drug effective, so the FDA is considering whether to withdraw its approval.
From 2018 to 2021, Medicaid spent $700 million at Makena.
As Lauren Gardner of POLITICO The accelerated approval program dates back to 1992, when the FDA was primarily responding to activists who claimed the agency was moving too slowly to approve potentially life-saving treatments to combat the AIDS epidemic. It will allow pharmaceutical companies to obtain rapid approval of potentially game-changing drugs based on preliminary trial results.
Most of the accelerated approvals granted in the last decade have been for cancer drugs.
Benefits of Fast Approval:
- Medicines can prolong life. America’s pharmaceutical research and manufacturers, lobbying pharmaceutical companies, Note that the drug has been accelerated approved Fighting multiple myeloma has added years to the lives of people with cancer.
- Patients will have faster access to new drugs. Cancer drugs reach patients a median 3.4 years earlier than using the FDA’s traditional approval process, according to PhRMA.
- It can take years for the FDA to revoke drug approvals that later fail to show efficacy in clinical trials or take a long time for manufacturers to complete testing.
- Drugs can give false hope to critically ill patients.
- Drugs cost insurance companies, including federal and state governments, billions of dollars. His Aduhelm’s FDA approval for Alzheimer’s disease is a drug that costs tens of thousands of dollars a year for each patient who uses it. boosted Medicare premiums last year.
A meeting of the FDA’s Obstetrics, Reproductive and Urology Drugs Advisory Committee on Makena continues tomorrow.
meeting passed a bipartisan bill Make it easier for sick veterans to get Veterans Disability and Medical Benefits this summer.
However new report It is poignant to assess how well the VA has done to care for veterans exposed to toxic fumes from burn scars. It raises questions about how government agencies will implement the new law.
The law automatically covers veterans suffering from dozens of medical conditions for benefits based on the presumption that smoke from burning pits is the cause of their illness.
of National Academy of Sciences, Academy of Engineering and Medicine It turns out that the registry that veterans use to track veterans who have been exposed to chemicals while serving in the military has fallen short of its goals.
The Academy found that the eight-year-old registry failed to:
- Promote research on health risks from exposure to airborne chemicals
- Monitor the health of veterans exposed on duty
In a statement to POLITICO, the VA said it would “consider all options” to fix the registry.
Mayo Clinic begins New peer-reviewed journal We focus on digital health innovation. It is scheduled to debut in early 2023.